Phase 2 Adenocarcinoma of the Pancreas Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
Neoadjuvant mFOLFIRINOX With Perioperative Oral Hydroxychloroquine in Resectable Pancreatic Adenocarcinoma
Adenocarcinoma of the Pancreas
West Virginia University40 enrolled1 locationNCT04911816
Recruiting
Phase 2
Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients
Adenocarcinoma of the Pancreas
National Cancer Institute, Naples240 enrolled5 locationsNCT05821556
Recruiting
Phase 1Phase 2
Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula
Adenocarcinoma of the PancreasAdenocarcinoma of the DuodenumAmpullary Adenocarcinoma
University Hospital, Lille36 enrolled1 locationNCT05116072
Recruiting
Phase 2
Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma
Pancreatic CancerAdenocarcinomaAdenocarcinoma of the Pancreas
Gulam Manji10 enrolled3 locationsNCT04543071
Recruiting
Phase 1Phase 2
Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer
Non-small Cell Lung CancerAdvanced Pancreatic AdenocarcinomaUnresectable Pancreatic Cancer+1 more
Dana-Farber Cancer Institute100 enrolled2 locationsNCT04789486